+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "GABAA Agonist"

GABAA Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

GABAA Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

GABAA agonists are a class of drugs used to treat a variety of conditions related to the central nervous system. These drugs act on the GABAA receptor, a type of neurotransmitter receptor found in the brain, to produce a calming effect. GABAA agonists are used to treat anxiety, insomnia, seizures, and other neurological disorders. They are also used to treat alcohol withdrawal and to reduce the symptoms of alcohol intoxication. GABAA agonists are available in both prescription and over-the-counter forms. Prescription GABAA agonists are typically used to treat more severe conditions, while over-the-counter GABAA agonists are used to treat milder conditions. Common prescription GABAA agonists include benzodiazepines, barbiturates, and non-benzodiazepines. Common over-the-counter GABAA agonists include melatonin and valerian root. The GABAA agonist market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Sanofi. Other companies in the market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more